Evaluation of intralipid effect on pregnancy outcomes in women with recurrent implantation failure: A retrospective cohort study
International Journal of Reproductive BioMedicine (IJRM) · 18.08.2026 · 24 (6)
DOI: 10.18502/ijrm.v24i6.21459 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Reproductive BioMedicine (IJRM), online erschienen am 18.08.2026. Verfasst von Atoosa Karimi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Recurrent implantation failure remains a challenge in assisted reproduction. Intralipid has been proposed as an immunomodulatory intervention to improve outcomes, although evidence remains inconsistent.
Objective
This study aimed to evaluate the effect of intralipid on pregnancy outcomes in women with a history of at least 2 failed embryo transfer cycles. Materials and Methods: In this retrospective cohort study, data of 270 women with ≥ 2 failed embryo transfer cycles, who underwent a subsequent frozen embryo transfer (FET) at Avicenna Fertility Center, Tehran, Iran, from March 2021–2022 were extracted from medical records. Participants were allocated to the intralipid group (n = 132), receiving 100 mL intravenous intralipid 20% 1 wk before FET, if beta-human chorionic gonadotropin was positive, the same dose was given every 4 wk until the end of the first trimester, or to the control group (n = 138), undergoing routine FET treatments. Outcomes included biochemical, clinical, and ongoing pregnancy, abortion, and live birth.
Results
Biochemical pregnancy rate was significantly higher in the intralipid group compared with controls (51.5% vs. 37.7%, p = 0.022). Clinical pregnancy (43.2% vs. 36.2%), ongoing pregnancy (28.8% vs. 18.8%), and live birth (25.8% vs. 17.4%) also favored the intralipid group, although these differences did not reach statistical significance (p > 0.05). Abortion rates were comparable between groups (25.8% vs. 21.0%, p = 0.357).
Conclusion
Intralipid may improve biochemical pregnancy rates and shows a non-significant positive trend in other pregnancy outcomes in recurrent implantation failure cases, warranting confirmation in larger randomized controlled trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pediatric Neurology, School of Medicine, Mofid Children's Hospital, Iranian Child Neurology Center of Excellence (ICNCE), Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences…
Zitieren
APA
Karimi, A., Dadgar, A., Saffari, H., Vahedi, N., Saket, S., & Arefi, S. (2026). Evaluation of intralipid effect on pregnancy outcomes in women with recurrent implantation failure: A retrospective cohort study. International Journal of Reproductive BioMedicine (IJRM), 24(6). https://doi.org/10.18502/ijrm.v24i6.21459
Vancouver
Karimi A, Dadgar A, Saffari H, Vahedi N, Saket S, Arefi S. Evaluation of intralipid effect on pregnancy outcomes in women with recurrent implantation failure: A retrospective cohort study. International Journal of Reproductive BioMedicine (IJRM). 2026;24(6). doi:10.18502/ijrm.v24i6.21459
BibTeX
@article{Karimi2026,
author = {Karimi, Atoosa and Dadgar, Aniseh and Saffari, Haniyeh and Vahedi, Nazanin and Saket, Sasan and Arefi, Soheila},
title = {Evaluation of intralipid effect on pregnancy outcomes in women with recurrent implantation failure: A retrospective cohort study},
journal = {International Journal of Reproductive BioMedicine (IJRM)},
year = {2026},
volume = {24},
number = {6},
doi = {10.18502/ijrm.v24i6.21459}
}
EUVIMED